Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Predictive and Prognostic Significance of Sodium Levels in Patients with NSCLC Treated by Erlotinib

MARTIN SVATON, ONDREJ FIALA, MILOS PESEK, FRANTISEK BRUHA, PETR MUKENSNABL, JAROSLAV RACEK, MAREK MINARIK and ZDENEK BORTLICEK
Anticancer Research December 2014, 34 (12) 7461-7465;
MARTIN SVATON
1Department of Pneumology and Phthisiology, Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: svatonm{at}gmail.com
ONDREJ FIALA
2Department of Oncology and Radiotherapy, Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MILOS PESEK
1Department of Pneumology and Phthisiology, Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FRANTISEK BRUHA
1Department of Pneumology and Phthisiology, Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PETR MUKENSNABL
3Department of Pathology, Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JAROSLAV RACEK
4Department of Chemistry and Biochemistry, Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAREK MINARIK
5Centre for Applied Genomics of Solid Tumours (CEGES), Genomac Research Institute, Prague, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ZDENEK BORTLICEK
6Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 34 no. 12 7461-7465
PubMed 
25503188

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received August 4, 2014
  • Revision received September 9, 2014
  • Accepted September 15, 2014
  • Published online December 12, 2014.

Copyright & Usage 
Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. MARTIN SVATON1⇑,
  2. ONDREJ FIALA2,
  3. MILOS PESEK1,
  4. FRANTISEK BRUHA1,
  5. PETR MUKENSNABL3,
  6. JAROSLAV RACEK4,
  7. MAREK MINARIK5 and
  8. ZDENEK BORTLICEK6
  1. 1Department of Pneumology and Phthisiology, Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic
  2. 2Department of Oncology and Radiotherapy, Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic
  3. 3Department of Pathology, Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic
  4. 4Department of Chemistry and Biochemistry, Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic
  5. 5Centre for Applied Genomics of Solid Tumours (CEGES), Genomac Research Institute, Prague, Czech Republic
  6. 6Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic
  1. Correspondence to: Martin Svaton, MUDr, Department of Pneumology and Phthisiology, Faculty of Medicine in Pilsen, Charles University in Prague, University Hospital Pilsen, Edvarda Benese 13, CZ-305 99 Pilsen, Czech Republic. Tel: +420 728129259, e-mail: svatonm{at}gmail.com
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 34, Issue 12
December 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Predictive and Prognostic Significance of Sodium Levels in Patients with NSCLC Treated by Erlotinib
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 13 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Predictive and Prognostic Significance of Sodium Levels in Patients with NSCLC Treated by Erlotinib
MARTIN SVATON, ONDREJ FIALA, MILOS PESEK, FRANTISEK BRUHA, PETR MUKENSNABL, JAROSLAV RACEK, MAREK MINARIK, ZDENEK BORTLICEK
Anticancer Research Dec 2014, 34 (12) 7461-7465;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Predictive and Prognostic Significance of Sodium Levels in Patients with NSCLC Treated by Erlotinib
MARTIN SVATON, ONDREJ FIALA, MILOS PESEK, FRANTISEK BRUHA, PETR MUKENSNABL, JAROSLAV RACEK, MAREK MINARIK, ZDENEK BORTLICEK
Anticancer Research Dec 2014, 34 (12) 7461-7465;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Efficacy of Platinum-based Chemotherapy for Platinum-sensitive Recurrent Ovarian Cancer During PARP Inhibitor Treatment: A Multicenter Retrospective Study
  • Uniformity Between Serological Biomarker Test, Esophago-gastro-duodenoscopy and Biopsy Histology in Triage of Upper Abdominal Symptoms in Gastroscopy Referral Patients
  • Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan
Show more Clinical Studies

Similar Articles

Keywords

  • hyponatremia
  • NSCLC
  • PFS
  • OS
  • prognosis
  • predictive marker
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire